Logo

Videos European Health Science Match

Sebastian Turner, Publisher, Der Tagesspiegel: 
Opening


Stefan Meuer, Chairman, BioRN: 
Opening

Ralf Kindervater, CEO, BIOPRO Baden-Württemberg: 
Welcome Keynote

Christian Tidona, Managing Director, BioRN: 
Moderation


Session 1: Understanding disease

Alexander Aulehla, European Molecular Biology Laboratory (EMBL): 
Self-Organization of Embryonic Genetic Oscillators into Spatiotemporal Wave Patterns

Carmen Nussbaum, Centre of Molecular Biology/DKFZ; Ruprecht-Karls-University, Heidelberg:
Combating Protein Misfolding in Neurodegenerative Diseases

Dagmar Ehrnhöfer, BioMedX: 
Exploiting biochemical changes in human neurodegenerative model systems for target discovery

Sebastian Haesler, Neuro-Electronics Research Flanders (NERF)/Catholic University of Leuven:
Nanotechnology for better research, diagnosis and treatment of brain disorders

Marc Thier, HI-STEM:
From Blood to Brain - Derivation of Patient Specific Neural Stem Cells from Blood and other Human Tissues

Marieke Essers, HI-STEM: 
Waking up hematopoietic and leukemic stem cells in vivo

Viktor Umansky, German Cancer Research Center (DKFZ)/University Medical Center Mannheim: 
Neutralization of immunosuppression induced by chronic inflammation in tumor microenvironment

Ariel Munitz, Sackler Medical School of the Tel-Aviv University: 
Eosinophils: The Underdog of the Tumor Microenvironment

Hai-Kun Liu, German Cancer Research Centre (DKFZ): 
Visualization and manipulation of cancer heterogeneity

Thorsten Zenz, National Center for Tumor Diseases (NCT): 
Molecular basis of drug response in leukemia and lymphoma

Rüdiger Rudolf, University of Applied Sciences Mannheim: 
Neuromuscular junction degeneration in muscle wasting

Paola Lovato, LEO Pharma A/S: 
Application of ex vivo culture of psoriasis skin and in vitro primary cell as model to investigate drug mode-of-action

Freddy Frischknecht, Center for Infectious Diseases/Heidelberg University Medical School: 
Imaging Malaria Transmission

Volker Stadler, Pepperprint, Karlsruhe Institute of Technology: 
Taking high-throughput synthesis to the next level: Laser-assisted microarray technology for infectious disease research

Benjamin Strobel, Boehringer Ingelheim: 
Modeling disease pathways using Adeno-associated virus vectors

Nina Cabezas-Wallscheid, HI-STEM: 
Your Dietary Habits Matter: Intake of Food Supplements Are Key for Maintaining Single Blood Stem Cells

Katrien Swerts, VIB Leuven: 
VIB: Where Sciences meets life

 

Session 2: Diagnosis

Stefan Barghorn, AbbVie: 
Monitoring Alzheimer’s Disease therapy with early biomarkers

Benedikt Brors, German Cancer Research Center (DKFZ): 
How will personalized oncology revolutionize cancer treatment?

Albrecht Stenzinger, IPH Center for Molecular Pathology/University of Heidelberg: 
Clinical implications of PDL1 copy number alterations: identification of core genetic regions, correlations with gene expression and mutational loads across 22 major cancer types

Gabriele Beer, Roche Diagnostics:
Comprehensive genomic profiling of solid tumors

Ronit Satchi-Fainaro, Sackler Faculty of Medicine/Tel Aviv University: 
Identifying molecular signatures of tumor dormancy as a basis for the rational design of precision nanomedicines

Lotte Themstrup, Zealand University Hospital: 
Diagnosing skin cancer by microvasculature 3D imaging

Walter von Stein, Miacom: 
Novel system for the identification of pathogens

Daniel Mark, SPINDIAG GmbH:
Fast and easy screening of patients for antibiotic-resistant bacteria during admission

Daniel Belstrøm, University of Copenhagen: 
Salivary microbiota for identification of oral diseases

Alexey Tarasov, BioMed X: 
Nanoelectronic biosensors for point-of-care diagnostics

Anne Röske, Hummingbird Diagnostics: 
Tracing miRNAs in blood for early and non-invasive disease detection

Christoph Sachsenmaier, Ribolution:
RIBOLUTION – Using non-coding RNA for the Next Generation in Diagnostics

Katja Jansen, Roche Diagnostics: 
Entering the era of Liquid Biopsy- detecting EGFR-mutations in the blood

Hamid Emminger, Women’s Hospital, University Hospitals of Heidelberg: 
MammaScreen, the way to the new gold standard: In vitro diagnosis of breast cancer at earliest stage

Ronny Schmidt, Sciomics: 
From Academics to Start-up to a healthier society

Ulrich Schotten, Maastricht University: 
Digital tools for personalized therapy of cardiac arrhythmia

Philipp Schatz, Metanomics Health: 
Early detection of heart failure using a metabolic biomarker

Gwendolyn Gramer, Centre for Paediatric and Adolescent Medicine/Heidelberg University Hospital: 
Newborn screening for metabolic disorders in Germany – Achievements and future perspectives


Session 3: Tools and Devices

Thorsten Röder, Hochschule Mannheim:
Micro reactors for chemical Production in Pharmaceutical Industry

Wilfried Braje, AbbVie: 
Chemistry Goes Green: From Organic Solvents to Water

Marcel Schmidt, EnzyPep B.V.:
CEPS Technology: A more efficient and greener route to future peptide drugs

Eric P. Bennett, University of Copenhagen:
Solving an unmet Genome Editing Need: Fast, Accurate and Robust Indel Detection by Amplicon Analysis (IDAA)

Orsolya Barabas, European Molecular Biology Laboratory (EMBL): 
Structure-based design for the advancement of transposon-based genetic engineering tools: the case of Sleeping Beauty

Kashif Sadiq, Heidelberg Institute for Theoretical Studies (HITS): 
Predictive synthetic retrovirology: A new paradigm for gene delivery

Matthew Baker, MERLN Institute/Maastricht University:
Static materials are no longer enough: Engineering dynamics into materials for tissue regeneration

Jennifer Patterson, Catholic University of Leuven:
Novel Peptide-Based Materials for Regenerative Medicine Applications

Aurélie Carlier, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University:
Talking to cells: surface topography as a tool to optimize biomaterials

Edward Lemke, European Molecular Biology Laboratory (EMBL): 
Novel custom biologics by clicking biology and chemistry together

Georg Kähler, University Hospital Mannheim: 
Smarter is better: Technology transfer from surgery to endoscopy

Nikolaos Deliolanis, Fraunhofer:
Multispectral Imaging for a new generation of surgical microscopes and endoscopes

Lena Maier-Hein, German Cancer Research Center (DKFZ):
Surgical data science for the operating room of the future

Kris Janssen, Catholic University of Leuven: 
Nanoscale imaging for technology development in biotechnology and materials

Lisa Hölting, Venneos GmbH: 
Introduction to CAN-Spectroscopy

Sébastien Equis, Nanolive: 
Marker-free phase nanoscopy

Oliver Heinze, Heidelberg University Hospital:
The new power in healthcare: Informed citizens and patients – A tool for self-determined, personalized digital healthcare management

Thomas Henzler, Medical Faculty Mannheim/University of Heidelberg: 
Surrogate-Imaging with Computed Tomography within the Context of Big Data

Oliver Schönborn-Kellenberger, Cogitars GmbH: 
How to change the world of statistics in times of big data

Daniel Paech, German Cancer Research Center (DKFZ):
Abbreviated and Contrast-agent-free breast magnetic resonance tomography with diffusion weighted imaging

Adnan Vilic, Zealand University Hospital/DTU: 
Feasibility of low-cost amplifiers for Brain-Computer Interfaces

Anne Mahringer, Heidelberg University: 
Drug Transport across the Blood-Brain Barrier

Bart de Taeye, Centre for Drug Design and Discovery (CD3) Leuven: 
Co-creating new drugs based on innovative academic science

Christoph Merten, European Molecular Biology Laboratory (EMBL): 
Living droplets – antibody discovery at high throughput

Antoinette Brink, PathoFinder BV Maastricht: 
Multiplex detection of 24 targets in real-time PCR within 2.5 hours

Sakshi Garg, Merck: 
Moving towards 3D cell culture based assays in drug screening

Günther Roth, BioCopy: 
Vaccine candidate screening

Jeroen Krijgsveld, Heidelberg University/German Cancer Research Center (DKFZ): 
Enhanced Proteomics Workflows with Paramagnetic Beads for Ultrasensitive Proteomics

Freimut Schliess, Profil Institut für Stoffwechselforschung GmbH:
E-healing of diabetes: the artificial pancreas for at home

Marius Rosenberg, Adhesys Medical GmbH: 
A revolutionary adhesive to stop bleeding and to control leakages


Session 4: Therapy

Bernhard K. Müller, AbbVie: 
Multiple Sclerosis Therapy: the next goal is neuroregeneration & neuroprotection

Axel Meyer, AbbVie: 
A 'Trojan Horse' strategy for brain delivery and therapy

Amir Amedi, Hebrew University of Jerusalem:
New Frontiers in sensory substitution and sensory recovery: Practical musical visual rehabilitation and underlying brain specialization & connectivity

Valentine Gesché, RWTH Aachen:
Patient individualised textile-based implants – the solution to a higher quality of life for patients and a better health care?

Joris Rotmans, Leiden University Medical Center: 
Tailoring the foreign body response for in situ vascular tissue engineering

Jan Siemens, Heidelberg University Hospital:
Inducing hypothermia: harnessing the beneficial effects of low body temperature on diverse disease states

André Huss Eriksson, LEO Pharma A/S: 
Treating skin diseases: On target in time

Theresa Bunse, Heidelberg Medical School/German Cancer Research Center (DKFZ): 
Molecularly-guided immunotherapy of brain tumors


Joe Lewis, European Molecular Biology Laboratory (EMBL): 
Small molecules with ant-cancer action

Andreas Pahl, Heidelberg Pharma: 
Amanitin-based Antibody-Drug-Conjugates as New Therapeutic Modalities for Cancer Therapy

Carsten Bahr, HI-STEM: 
Regulating stem cell function from long distances - Targeting super-enhancers in stem cells and cancer stem cells

Frauke Christ, Catholic University of Leuven: 
Lessons learned : HIV points the way towards precision treatment of mixed lineage leukemia

Noam Shomron, Tel Aviv University (TAU):
Big Data in Genomics: Stopping the Spread of Breast Cancer

Georg Gdynia, Heidelberg University Hospital: 
Targeting tumor glycolysis in cancer treatment

Gerard Drewes, Cellzome:
Hot cells - Mapping Proteome Wide Drug Bindin


Simone Fulle, BioMed X: 
Towards the rational design of selective kinase inhibitors - by novel in silico methods

Shannon Layland, Fraunhofer IGB Stuttgart:
The protective effect of the extracellular matrix in cardiovascular regenerative medicine

Thomas Thum, Institute of Molecular and Translational Therapeutic Strategies/Hannover Medical School: Translational Noncoding RNA approaches as innovative strategy to cure heart failure

Patrick Most, Heidelberg University/uniQure GmbH: 
InoCard’s heart failure gene therapy: from award-winning academic concept to advanced therapy medicinal product development

Lotte Coelmont, Catholic University of Leuven:
Introduction to a novel vaccine approach  PLLAV: the plasmid-launched live-attenuated viral vaccine platform


Sebastian Turner, Publisher, Der Tagesspiegel &Christian Tidona, Managing Director, BioRN
Farewell